Professional Documents
Culture Documents
Duchenne Muscular Dystrophy
(DMD)
Learning objectives
• Describe the mechanism of X chromosome inactivation
– Describe which parts of the chromosome is always exempted from inactivation, and that
recombination in PAR regions are necessary parts of male meiosis
• State and apply the risk for a heterozygote female for showing symptoms of an X‐linked recessive
disease due to skewed X chromosome inactivation
• Describe the likely X inactivation pattern in a female carrying a translocation of one X chromosome
and an autosome
• For the most severe X‐linked recessive diseases, state and apply the risk for an isolated case of being
result of a new mutation versus having inherited the mutation from his mother
• Recognize Duchenne muscular dystrophy as a very severe X‐linked recessive disease caused by
Dystrophin mutations
– Recognize Becker MD as a mild form of DMD
– Describe DMD and BMB phenotypes
– Compare and contrast the likely mutation types in these two forms
• Discuss the most likely molecular pathological mechanisms for DMD.
• Describe that due to dystrophin being involved in protein complexes, a patient with DMD‐like
phenotype has a significant probability for having a different disease
• Sample questions will be available in Osmosis (also if you only use the free version of Osmosis,
but you need to be registered with your Ross email)
DMD – the essentials
• X‐linked recessive
• Genetic lethal in males
• Due to lack of Dystrophin protein
• Onset of symptoms before age 5
• Relatively common: 1/4000 – 1/6000 males
• Mild versions = Becker Muscular Dystrophy
(BMD) – protein present
What is the probability that the
mother is a carrier
*•*.*•pxnxw
1. 1
2. ½
Xny
XX "
3. ¼
4. 2/3
5. 1/3
0% 0% 0% 0% 0%
1 ½ ¼ 2/3 1/3
What is the probability that the sister
is a carrier
*
n
*
1. 1
2. ½
xypFEMI.tl/nYxnyXNXexiBii#Ixi
3. ¼
4. 2/3
5. 1/3
0% 0% 0% 0% 0%
1 ½ ¼ 2/3 1/3
The sister has been shown to be a carrier.
What is her approximate probability for
showing at least some symptoms?
XNY xnxw
1. 1
XNXN
Xnyxny
2. ½
3. ¼
4. 0
observed at 5- 10%
5. 1/10 blc
0% 0% 0% 0% 0%
1 ½ ¼ 0 1/10
Answer to previous slide
• Expected: about 0%
• Observed: 5‐10%
• Explanation is related to X‐chromosome
inactivation, explained in the next section
X‐chromosome inactivation
(example of epigenetics)
Why?
• X‐chromosome contains about 2000 genes not
found in the Y
• For most of these, males and females need
the same amount of product
• Easiest fix is to inactivate all X chromosomes
beyond one
* inactivation
When
occurs ...
• At late blastula (2000‐10000 cells?) stage of
embryo development
• Each cell inactivates one X independent of
other cells
• For that cell and all its descendants, X
inactivation is irreversible
How?
• Three main players on the X:
– XIC (X‐inactivation center), physically overlapping
XIST at Xq13.2
– XIST (X inactivation‐specific transcript) a non‐
coding mRNA of 17 kb
– its antisense transcript TSIX
How (2)
• During embryonal development in an embryo
with 2 X chromosomes:
• The two copies of XIC transiently align
• XIST and TSIX reciprocally get up‐ and down‐
regulated
• On the chromosome with up‐regulated XIST,
the RNA spreads and covers that chromosome
• This initiates X inactivation
How (3)
• Downstream events include:
– DNA methylation
– Histone modifications
– Accumulation of variant histone
– Asynchronous replication
– RNA polymerase II exclusion
• Once taken place, XIST expression is no longer
necessary
• The downstream events are similar to those
happening in imprinting, and both events are
examples of epigenetic changes
has to come from two X chromosomes , indicating
female cut ! ( )
Klinefelter
too
seen though
B O
The Tri-colored Cat
• Orange is caused by a X-linked dominant allele at
the O locus
• Black is phenotype if there is no active O alleles
(males, homozygous females, or inactive-X
heterozygotes)
• (White is caused by a dominant autosomal allele
for white spots (ignore this!))
• Tri-colored is called Calico among US cat-lovers
Expected outcome
• In a woman’s body half the cells express
Both Xs activated I reactivated in
inactivation
Wli inactivation Center
chromosome
of one X leads to
of the
opposite X
1. Cell death
X
2. No problem
3. Faster growth
8 0% 0% 0%
Cell death No Faster
problem growth
X‐autosomal translocations
Monty
?
;*µx
LESS -
likely
Bfxl
*
t.sk
eraiwhkwlbpamdssion
odmdm
• A carrier of a balanced :*
:*
translocation will have most cells
inactivating the normal X
• If she has disease causing allele on M
DMD
the translocation chromosome, X
then she will express the disease
8
Exceptions to X inactivation
• XIST!
• Several genes necessary for normal
reproduction
• Pseudoautosomal regions (PAR)
• Some other genes randomly distributed
within the inactive area (different among
women)
Pseudoautosomal regions (PAR)
X Y
• Identical regions between X and Y PAR1
• PAR1 contains about 13 genes,
PAR2 about 4
• Crossover in PAR1 necessary in male
meiosis PAR 2
– Crossover may happen in PAR2
Duchenne’s Muscular Dystrophy
(DMD)
gower
's
sign
:
get up off floor this
way due to
hip weakness
BMD
• Typically presents in a teenager
• Progress slowly
• May never need wheelchair
• Dystrophin present
Dystrophin Gene
• The gene is huge = 2.3 million basepairs
• The mRNA encoded is 14 kb from 79 exons
• 1/3 of cases involve new mutations meaning is
mother not carrier
• Protein is large, associated with sarcolemma,
involved in linking extracellular laminin with
intracellular thin filaments
Dystrophin mutation types in
DMD/BMD
DMD BMD
Deletion % 72% 85%
Deletion types Disrupts
Conserves
Several exams at same time
reading frame
reading frame
Point mutations 15‐20%
Less
Partial duplications 6‐10%
6‐10%
Protein Absent
Present but
usually
abnormal size
About 10% of patients with DMD/BMD‐like symptoms
does not have mutation in dystrophin
Dystrophin and associated complexes
Mutation of most of these also result in muscular dystrophies
Notes for figure
• Sarcoglycans, dystroglycans, etc form a tight
complex that fall apart if dystrophin is missing
µ most frequent Other than DMD BMD
– Limb girdle muscular dystrophy and other dystrophies
,
result from mutation in these proteins
• nNOS is a nitric oxide synthase necessary for
exercise induced vasodilation
– If missing leads to ischemia in the muscle
• In addition to ischemia, lack of physical coupling
of cytoskeleton and extracellular matrix is
probably involved in the pathology of DMD/BMD
Laboratory
• High creatine kinase is always a sign of muscle
degradation, and CK is elevated before clinical signs
become obvious
– Seen in 70% of female heterozygotes for DMD
1. In the DNA lab, PCR amplification, ligation, or southern
blot can show the presence/absence of single/multiplex
exons but usually will not detect all
2. If negative, follow up with muscle biopsy for dystrophin
detection
3. If dystrophin absent possible to follow up with e.g.,
sequencing to detect specific mutation and thereafter
look for carriers in female relatives
Pre‐pregnancy/prenatal counseling of
female carriers
• Purpose: provide info for reproductive decisions.
1. Going through with any pregnancy, OR
2. Trying to avoid giving birth to a child with DMD
• Should include
– Explanation of DMD (keep neutral)
– Explanation of options for “2” including risks of such
options
– Parents can opt out of counseling at any time
– Parents/mother make(s) the final decision
Re option 2: Prenatal screening
• It is not always possible to test for
presence/absence of the mutation (if possible
usually late in pregnancy)
• It is possible to test for sex of fetus very early
• Termination of pregnancy with male fetus is
one way to ensure not giving birth to child
with DMD
Other Similar Diseases
• Becker’s muscular dystrophy
– Caused by other mutations in the DMD gene;
milder symptoms, later onset
• Limb girdle muscular dystrophy
– Caused by mutations in any of a large number of
genes
– LGMD1 is autosomal dominant
– LGMD2 recessive inheritance; gene products
generally interact with dystrophin
The isolated X-linked case: DMD
and other very severe diseases
• Isolated = only one affected in
family
• The mother can be a carrier, XXM XY XX
(2/3)
• OR, the mother can be a non-
carrier, new mutation to blame *
(1/3)
Y XM
• The mother might have gonadal
mosaicism (unknown percentage)
* denotes new mutation
What is the risk that the sister
(II-1) is a carrier?
XNY
1. 2/3 3
XNXNZ
2. 1/2 xnxt xny
3. 1/3 could be inherited ,
could be new mutation
4. 1/4
5. 1/5 *x¥¥y¥¥
6. 1/6 0% 0% 0% 0% 0% 0%
lz °
2-3 =
tg 2/3 1/2 1/3 1/4 1/5 1/6
What is the risk that the first
child (III-1) will be affected
XNY XNXN
1. 1/4
2. 1/6 's
by
XNX XNY
XNY
,
1,3
3. 1/8
tz
4. 1/10 °
Thana of
°
tzlboylgirl )
in activating
5. 1/12 Chance
ihhenhhy
of
bad allele
bad X
from mom
0% 0% 0% 0% 0%
tz . 1 .
+2 .
tz =
tz 1/4 1/6 1/8 1/10 1/12